Detailed information for compound 1768207

Basic information

Technical information
  • TDR Targets ID: 1768207
  • Name: 2-[[2-(4-bromophenyl)sulfanylacetyl]amino]ben zoic acid
  • MW: 366.23 | Formula: C15H12BrNO3S
  • H donors: 2 H acceptors: 3 LogP: 4.11 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1ccccc1C(=O)O)CSc1ccc(cc1)Br
  • InChi: 1S/C15H12BrNO3S/c16-10-5-7-11(8-6-10)21-9-14(18)17-13-4-2-1-3-12(13)15(19)20/h1-8H,9H2,(H,17,18)(H,19,20)
  • InChiKey: CDLIBRQUNAUJEQ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[[2-[(4-bromophenyl)thio]-1-oxoethyl]amino]benzoic acid
  • 2-[[2-[(4-bromophenyl)thio]acetyl]amino]benzoic acid
  • 2-[2-(4-bromophenyl)sulfanylethanoylamino]benzoic acid
  • STK279035

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Tumor necrosis factor receptor superfamily member 6 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.0712 1 1
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0712 1 0.5
Loa Loa (eye worm) isocitrate dehydrogenase 0.0712 1 1
Wolbachia endosymbiont of Brugia malayi isocitrate dehydrogenase 0.0086 0 0.5
Toxoplasma gondii isocitrate dehydrogenase 0.0712 1 0.5
Trichomonas vaginalis isocitrate dehydrogenase, putative 0.0086 0 0.5
Mycobacterium leprae PROBABLE 3-ISOPROPYLMALATE DEHYDROGENASE LEUB (BETA-IPM DEHYDROGENASE) (IMDH) (3-IPM-DH) 0.0086 0 0.5
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0712 1 1
Mycobacterium ulcerans 3-isopropylmalate dehydrogenase 0.0086 0 0.5
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative 0.0712 1 0.5
Trypanosoma brucei isocitrate dehydrogenase, putative 0.0712 1 0.5
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.0712 1 1
Toxoplasma gondii isocitrate dehydrogenase 0.0712 1 0.5
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0712 1 1
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0712 1 1
Entamoeba histolytica tartrate dehydrogenase, putative 0.0086 0 0.5
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0712 1 1
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0712 1 0.5
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.0712 1 1
Trypanosoma cruzi isocitrate dehydrogenase, putative 0.0712 1 0.5
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial 0.0712 1 0.5
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.0712 1 1
Echinococcus multilocularis isocitrate dehydrogenase 0.0712 1 1
Brugia malayi Isocitrate dehydrogenase 0.0712 1 1

Activities

Activity type Activity value Assay description Source Reference
EC50 (binding) = 5.65 Inhibition of Fas-mediated cell death in oxygen and glucose deprived rat H9c2 cells treated 30 mins before oxygen and glucose deprivation measured after 6 hrs by DAPI staining ChEMBL. 23916254
Inhibition (binding) = 30.86 % Inhibition of Fas-mediated cell death in oxygen and glucose deprived rat H9c2 cells at 10 uM treated 30 mins before oxygen and glucose deprivation measured after 6 hrs by DAPI staining ChEMBL. 23916254

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.